Saladax Biomedical Revenue and Competitors
Estimated Revenue & Valuation
- Saladax Biomedical's estimated annual revenue is currently $5.3M per year. 0
- Saladax Biomedical's total funding is $54.9M.
Employee Data
- 00
Saladax Biomedical's People
Name | Title | Email/Phone |
---|---|---|
1 | PRESIDENT & CEO | Reveal Email/Phone |
2 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
3 | VP, R&D and Operations | Reveal Email/Phone |
4 | SVP, Development/Straegist | Reveal Email/Phone |
5 | Chief Operations Officer | Reveal Email/Phone |
6 | Manager Operations | Reveal Email/Phone |
7 | Sales Development Representative | Reveal Email/Phone |
8 | President and CEO | Reveal Email/Phone |
9 | Dir STRATEGIC ACCOUNTS | Reveal Email/Phone |
10 | Research Fellow | Reveal Email/Phone |
Saladax Biomedical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Saladax Biomedical?
Saladax is a personalized medicine diagnostics company that has developed immunoassay technology for dose management of chemotherapy agents. Saladax assays are evidence-based tools that help guide the clinician in providing effective and safe drug therapy to individual patients. Most cancer drugs have a narrow therapeutic index and a dose limiting toxicity profile that make these drugs ideal candidates for dose management through the measurement of drug concentrations in blood. These simple blood tests enable an oncologist to optimize dosing for target drug levels to achieve optimal balance of efficacy and toxicity, where the loss of this balance can have devastating effects on patients
keywords:N/A$54.9M
Total Funding
N/A
Number of Employees
$5.3M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Saladax Biomedical News
... firm Saladax Biomedical is looking to change that with an agreement announced last month with Danaher subsidiary Beckman Coulter.
Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests. April 05, 2022 09:05 AM Eastern Daylight Time.
Saladax Biomedical, Inc. Announces Global Distribution Agreement With Beckman Coulter, Inc. for Antipsychotic Drug Tests ... BETHLEHEM, Pa.--(...
BETHLEHEM, Pa.–(BUSINESS WIRE)–June 26, 2018– Saladax Biomedical, Inc., a diagnostics company providing kits to measure drug blood levels for adherence and medication management, has signed a license agreement with Janssen Pharmaceutica, NV, one of the Janssen Pharmaceutical Companies of Johnso ...
Saladax Biomedical, Inc., a Bethlehem, Pennsylvania-based company developing and commercializing novel diagnostic assays, received a $22.4m strategic equity investment. The backer was Shanghai Fosun Pharmaceutical Co., Ltd. (Fosun Pharma: 600196.SH), a pharmaceutical and healthcare company in t ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $134.9M | 0 | N/A | N/A |
#2 | $84M | 0 | N/A | N/A |
#3 | $0.1M | 1 | -50% | N/A |
#4 | $0.1M | 1 | 0% | N/A |
#5 | $0.2M | 2 | N/A | N/A |